Optipharm.CO.LTD (153710) — Working Capital to Net Assets Ratio
Optipharm.CO.LTD (153710) has a Working Capital to Net Assets ratio of 10.3% as of December 2025. Working capital of ₩2.62 Billion (current assets of ₩15.24 Billion minus current liabilities of ₩12.63 Billion) is measured against net assets of ₩25.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Optipharm.CO.LTD balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Optipharm.CO.LTD Working Capital to Net Assets (2015–2025)
This chart shows how Optipharm.CO.LTD's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 10.3%, reflecting working capital of ₩2.62 Billion against net assets of ₩25.40 Billion KRW. Check Optipharm.CO.LTD tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Optipharm.CO.LTD (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Optipharm.CO.LTD from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Optipharm.CO.LTD.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.3% | ₩2.62 Billion | ₩25.40 Billion | ₩15.24 Billion | ₩12.63 Billion | ▼ -11.4 pp |
| 2024 | 21.7% | ₩5.94 Billion | ₩27.34 Billion | ₩18.67 Billion | ₩12.73 Billion | ▼ -13.6 pp |
| 2023 | 35.3% | ₩8.87 Billion | ₩25.14 Billion | ₩20.48 Billion | ₩11.60 Billion | ▼ -7.0 pp |
| 2022 | 42.3% | ₩12.28 Billion | ₩29.01 Billion | ₩21.55 Billion | ₩9.26 Billion | ▼ -15.9 pp |
| 2021 | 58.2% | ₩18.02 Billion | ₩30.96 Billion | ₩25.87 Billion | ₩7.85 Billion | ▼ -1.5 pp |
| 2020 | 59.7% | ₩20.15 Billion | ₩33.78 Billion | ₩25.68 Billion | ₩5.52 Billion | ▼ -6.8 pp |
| 2019 | 66.5% | ₩23.66 Billion | ₩35.61 Billion | ₩28.03 Billion | ₩4.37 Billion | ▲ +0.8 pp |
| 2018 | 65.6% | ₩23.27 Billion | ₩35.44 Billion | ₩29.04 Billion | ₩5.77 Billion | ▲ +66.6 pp |
| 2017 | -1.0% | ₩-123.47 Million | ₩12.79 Billion | ₩5.86 Billion | ₩5.98 Billion | ▼ -3.1 pp |
| 2016 | 2.1% | ₩281.57 Million | ₩13.50 Billion | ₩6.55 Billion | ₩6.27 Billion | ▲ +230.6 pp |
| 2015 | -228.5% | ₩-9.82 Billion | ₩4.30 Billion | ₩2.55 Billion | ₩12.37 Billion | — |